Monitoring Atrial Fibrillation After Catheter Ablation
- PMID: 27957062
- PMCID: PMC5135239
- DOI: 10.4022/jafib.1040
Monitoring Atrial Fibrillation After Catheter Ablation
Abstract
Although catheter ablation is an effective treatment for recurrent atrial fibrillation (AF), there is no consensus on the definition of success or follow-up strategies. Symptoms are the major motivation for undergoing catheter ablation in patients with AF, however it is well known that reliance on perception of AF by patients after AF ablation results in an underestimation of recurrence of the arrhythmia. Because symptoms of AF occurrence may be misleading, a reliable assessment of rhythm outcome is essential for the definition of success in both clinical care and research trials. Continuous rhythm monitoring over long periods of time is superior to intermittent recording using external monitors to detect the presence of AF episodes and to quantify the AF burden. Today, new devices implanted subcutaneously using a minimally invasive technique have been developed for continuous AF monitoring. Implantable devices keep detailed information about arrhythmia recurrences and might allow identification of very brief episodes of AF, the significance of which is still uncertain. In particular, it is not known whether there is any critical value of daily AF burden that has a prognostic significance. This issue remains an area of active discussion, debate and investigation. Further investigation is required to determine if continuous AF monitoring with implantable devices is effective in reducing stroke risk and facilitating maintenance of sinus rhythm after AF ablation.
Keywords: Atrial Fibrillation; Catheter Ablation; Continuous Monitoring; Implantable Cardiac monitor; Loop Recorders; Remote Monitoring; Silent Atrial Fibrillation.
References
-
- Kannel W B, Abbott R D, Savage D D, McNamara P M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N. Engl. J. Med. 1982 Apr 29;306 (17):1018–22. - PubMed
-
- Vidaillet Humberto, Granada Juan F, Chyou P o-Huang, Maassen Karen, Ortiz Mario, Pulido Juan N, Sharma Param, Smith Peter N, Hayes John. A population-based study of mortality among patients with atrial fibrillation or flutter. Am. J. Med. 2002 Oct 1;113 (5):365–70. - PubMed
-
- Benjamin E J, Wolf P A, D'Agostino R B, Silbershatz H, Kannel W B, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998 Sep 8;98 (10):946–52. - PubMed
-
- Wazni Oussama M, Marrouche Nassir F, Martin David O, Verma Atul, Bhargava Mandeep, Saliba Walid, Bash Dianna, Schweikert Robert, Brachmann Johannes, Gunther Jens, Gutleben Klaus, Pisano Ennio, Potenza Dominico, Fanelli Raffaele, Raviele Antonio, Themistoclakis Sakis, Rossillo Antonio, Bonso Aldo, Natale Andrea. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005 Jun 1;293 (21):2634–40. - PubMed
-
- Stabile Giuseppe, Bertaglia Emanuele, Senatore Gaetano, De Simone Antonio, Zoppo Franco, Donnici Giovanni, Turco Pietro, Pascotto Pietro, Fazzari Massimo, Vitale Dino Franco. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur. Heart J. 2006 Jan;27 (2):216–21. - PubMed